This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Sep;364(9438):933-4; author reply 935.

doi: 10.1016/S0140-6736(04)17013-X.

VALUE: analysis of results

PMID: 15364180
DOI: 10.1016/S0140-6736(04)17013-X

Free article

Comment

VALUE: analysis of results

Peter Sever. Lancet. 2004 Sep.

Free article

. 2004 Sep;364(9438):933-4; author reply 935.

doi: 10.1016/S0140-6736(04)17013-X.

Author

PMID: 15364180
DOI: 10.1016/S0140-6736(04)17013-X

No abstract available

PubMed Disclaimer

Comment on

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A; VALUE trial group. Julius S, et al. Lancet. 2004 Jun 19;363(9426):2022-31. doi: 10.1016/S0140-6736(04)16451-9. Lancet. 2004. PMID: 15207952 Clinical Trial.

Similar articles

Angiotensin receptor blockers and myocardial infarction.
Verma S, Strauss M. Verma S, et al. BMJ. 2004 Nov 27;329(7477):1248-9. doi: 10.1136/bmj.329.7477.1248. BMJ. 2004. PMID: 15564232 Free PMC article. No abstract available.
Angiotensin receptor blockers and myocardial infarction: the importance of dosage.
Sarzani R, Dessì-Fulgheri P. Sarzani R, et al. J Hypertens. 2006 Aug;24(8):1679-81; author reply 1681-2. doi: 10.1097/01.hjh.0000239307.86248.80. J Hypertens. 2006. PMID: 16877973 No abstract available.
Two amlodipine/ARB combinations for hypertension.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2007 Dec 17;49(1276):101-2. Med Lett Drugs Ther. 2007. PMID: 18084152 No abstract available.
Aliskiren/valsartan (Valturna) for hypertension.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2009 Nov 30;51(1326):94-5. Med Lett Drugs Ther. 2009. PMID: 20224524 Review. No abstract available.
Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.
Bos-Thompson MA, Hillaire-Buys D, Muller F, Dechaud H, Mazurier E, Boulot P, Morin D. Bos-Thompson MA, et al. Ann Pharmacother. 2005 Jan;39(1):157-61. doi: 10.1345/aph.1E250. Epub 2004 Dec 8. Ann Pharmacother. 2005. PMID: 15590878 Review.

See all similar articles

Cited by

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials.
Makani H, Bangalore S, Desouza KA, Shah A, Messerli FH. Makani H, et al. BMJ. 2013 Jan 28;346:f360. doi: 10.1136/bmj.f360. BMJ. 2013. PMID: 23358488 Free PMC article.
Valsartan/hydrochlorothiazide: a review of its use in the management of hypertension.
Wagstaff AJ. Wagstaff AJ. Drugs. 2006;66(14):1881-901. doi: 10.2165/00003495-200666140-00011. Drugs. 2006. PMID: 17040120 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- CORE
- Elsevier Science
Medical
- MedlinePlus Health Information